Evidence map›Paper›PMID 41917391›Full record

ReviewAdvances in experimental medicine and biology2026

New Sialic Acid-Binding Site of SIGLEC-7.

Sayo Morishita, Masaya Hane, Nao Yamakawa, Ken Kitajima, Chihiro Sato

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Prediction of Novel Disease-Related Regions in SIGLEC-7 byInternational journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sayo MorishitaGraduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Masaya HaneGraduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Nao YamakawaIntegrated Glyco-Biomedical Research Center (iGMED), Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan.
Ken KitajimaGraduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Chihiro SatoGraduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan. chi@agr.nagoya-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sialic acid is a code for "recognize-me-as-self" (a "see-me-as-self" signal) on cells or molecules for immune cells that survey non-self-items. One of the mechanisms in discrimination of self- and non-self-items is the presence of sialic acid-binding immunoglobulin-like lectins (SIGLECs) on the immune cell surface. SIGLECs have a dual role with respect to host cells in the innate immune system. Under normal conditions, the ability of SIGLECs to discriminate non-self from self is important in inhibiting attacks on the self-cells. However, cancer cells and sometimes bacterial cells can misuse this system, using more sialic acid to cheat immune cells, as if they are self-cells, resulting in escape from the host immune system. SIGLEC-7 is an important inhibitory receptor predominantly expressed in natural killer cells. The ligand specificity of SIGLEC-7 is diverse and complex, and its surveillance mechanisms are unclear. In this chapter, we focus on ligand specificity from two perspectives. One is the clustering effect of the ligand on SIGLEC-7, and the other is a new sialic acid-binding site in addition to that previously discovered in SIGLEC-7. These perspectives inform the decoding of true biological contexts within the SIGLEC-sialic acid axis.

Indexed as

Antigens, Differentiation, MyelomonocyticLectinsN-Acetylneuraminic AcidAnimalsBinding SitesHumansImmunity, InnateKiller Cells, NaturalLigandsSialic Acid Binding Immunoglobulin-like LectinsAntigens, Differentiation, MyelomonocyticLectinsLigandsN-Acetylneuraminic AcidSialic Acid Binding Immunoglobulin-like LectinsSIGLEC7 protein, humanClusterInnate immune systemLectinMultivalencySialic acidSiglec

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.